Results 161 to 170 of about 11,979 (257)

Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer [PDF]

, 2010
Ryo Sakai, Shunsuke Kagawa, Yasumoto Yamasaki, Toru Kojima, Futoshi Uno, Yuuri Hashimoto, Yuichi Watanabe, Yasuo Urata, Noriaki Tanaka, Toshiyoshi Fujiwara   +9 more
openalex   +1 more source

Comparative safety and efficacy of oncolytic virotherapy for the treatment of individuals with malignancies: a systematic review, meta-analysis, and Bayesian network meta-analysis. [PDF]

EClinicalMedicine
Lau P, Liang L, Chen X, Zhang J, Liu H.
europepmc   +1 more source

MicroRNA-regulated transgene expression systems for gene therapy and virotherapy [PDF]

, 2011
Fuminori Sakurai
openalex   +1 more source

Induction of abscopal effect combining H101 oncolytic virotherapy with tislelizumab in a patient with advanced hepatocellular carcinoma: a case report. [PDF]

Am J Cancer Res
Ou D, Li Y, Wu J, Ou S, Xie F.
europepmc   +1 more source

A mathematical model for cell cycle-specific cancer virotherapy [PDF]

, 2011
Joseph J. Crivelli, Juraj Földes, Peter Kim, Joanna R. Wares   +3 more
openalex   +1 more source

Oncolytic virotherapy and tumor microenvironment modulation. [PDF]

Clin Exp Med
Rivera-Orellana S, Bautista J, Palacios-Zavala D, Ojeda-Mosquera S, Altamirano-Colina A, Alcocer-Veintimilla M, Parrales-Rosales G, Izquierdo-Condoy JS, Vásconez-González J, Ortiz-Prado E, Muslin C, López-Cortés A.   +11 more
europepmc   +1 more source

A Transductionally Retargeted Adenoviral Vector for Virotherapy of Her2/neu-Expressing Prostate Cancer [PDF]

, 2011
Maria K. Magnusson, Robert Kraaij, Regina Leadley, C.M.A. De Ridder, Wytske M. van Weerden, K.A.J. Van Schie, Mark van der Kroeg, Rob C. Hoeben, Norman J. Maitland, Leif Lindholm   +9 more
openalex   +1 more source

Oncolytic virus VG161 offers new hope for refractory liver cancer. [PDF]

Front Oncol
Li J, Zhou H, Wang X, Huang K, Wang Y.
europepmc   +1 more source

Immunostimulatory virotherapy using recombinant sendai virus as a new cancer therapeutic regimen

, 2008
Yoshikazu Yonemitsu
openalex   +1 more source

Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy [PDF]

, 2011
Timothy Kottke, John Chester, Elizabeth J. Ilett, Jill Thompson, Rosa María Díaz, Matt Coffey, Peter J. Selby, Gerard J. Nuovo, José S. Pulido, Debabrata Mukhopadhyay, Hardev Pandha, Kevin J. Harrington, Alan Melcher, Richard G. Vile   +13 more
openalex   +1 more source